Saturday , November 18 2017
Home / Therapies / Meglitinides (page 2)

Meglitinides

Postprandial Hyperglycemia and Increased Cardiovascular Risk

Hyperglycemia is a major risk factor for both the microvascular and macrovascular complications in patients with Type 2 diabetes. This review summarizes the cardiovascular results of large outcomes trials in diabetes and presents new evidence on the role of hyperglycemia, with particular emphasis on postprandial hyperglycemia, in adverse cardiovascular outcomes …

Read More »

Endo’s Issue Consensus Statement on Pre-Diabetes

It is good to see that there is more concern for those at risk for diabetes. The treatment of pre-diabetes requires intensive lifestyle modification and the use of metformin and acarbose for controlling glycemia for high-risk patients, declared a consensus statement issued by the American College of Endocrinology task force.

Read More »